Siemens Healthineers Ag Stock Current Valuation
| SHL Stock | EUR 52.16 0.14 0.27% |
Valuation analysis of Siemens Healthineers helps investors to measure Siemens Healthineers' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Siemens Healthineers' price fluctuation is very steady at this time. Calculation of the real value of Siemens Healthineers is based on 3 months time horizon. Increasing Siemens Healthineers' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Siemens stock is determined by what a typical buyer is willing to pay for full or partial control of Siemens Healthineers AG. Since Siemens Healthineers is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Siemens Stock. However, Siemens Healthineers' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 52.16 | Real 55.17 | Hype 52.16 |
The real value of Siemens Stock, also known as its intrinsic value, is the underlying worth of Siemens Healthineers Company, which is reflected in its stock price. It is based on Siemens Healthineers' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Siemens Healthineers' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Siemens Healthineers AG helps investors to forecast how Siemens stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Siemens Healthineers more accurately as focusing exclusively on Siemens Healthineers' fundamentals will not take into account other important factors: Siemens Healthineers AG Company Current Valuation Analysis
Siemens Healthineers' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Siemens Healthineers Current Valuation | 56.35 B |
Most of Siemens Healthineers' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Siemens Healthineers AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Siemens Healthineers AG has a Current Valuation of 56.35 B. This is 292.32% higher than that of the Healthcare sector and significantly higher than that of the Diagnostics & Research industry. The current valuation for all Germany stocks is significantly lower than that of the firm.
Siemens Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Siemens Healthineers' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Siemens Healthineers could also be used in its relative valuation, which is a method of valuing Siemens Healthineers by comparing valuation metrics of similar companies.Siemens Healthineers is rated fourth in current valuation category among its peers.
Siemens Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0383 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 56.35 B | |||
| Shares Outstanding | 1.12 B | |||
| Shares Owned By Insiders | 75.30 % | |||
| Shares Owned By Institutions | 11.84 % | |||
| Price To Earning | 34.79 X | |||
| Price To Book | 3.12 X | |||
| Price To Sales | 2.48 X | |||
| Revenue | 21.71 B | |||
| Gross Profit | 8.14 B | |||
| EBITDA | 4.26 B | |||
| Net Income | 2.04 B | |||
| Cash And Equivalents | 1.47 B | |||
| Cash Per Share | 1.32 X | |||
| Total Debt | 15 M | |||
| Debt To Equity | 0.97 % | |||
| Current Ratio | 1.13 X | |||
| Book Value Per Share | 16.77 X | |||
| Cash Flow From Operations | 2.5 B | |||
| Earnings Per Share | 1.79 X | |||
| Target Price | 0.2 | |||
| Number Of Employees | 70.1 K | |||
| Beta | 0.61 | |||
| Market Capitalization | 55.8 B | |||
| Total Asset | 49.06 B | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 49.06 B | |||
| Last Dividend Paid | 0.95 |
About Siemens Healthineers Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Siemens Healthineers AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Siemens Healthineers using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Siemens Healthineers AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Siemens Stock
Siemens Healthineers financial ratios help investors to determine whether Siemens Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Siemens with respect to the benefits of owning Siemens Healthineers security.